Drugs / 17B-estradiol
17B-estradiol
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05900895 | Jul 2024 → Dec 2027 expected | breast cancer | Mary D Chamberlin | Recruiting | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02188745 | Mar 2016 → Jan 2024 | breast cancer | Dartmouth-Hitchcock Medical Center | Completed | No outcome recorded |
| Phase 2/31 trial · 1 met primary | ||||||
| Phase 2/3 | NCT00115024 | Apr 1994 → Nov 1998 | atherosclerosis | National Institute on Aging (NIA) | Completed | Met primary |
| Phase 42 trials | ||||||
| Phase 4 | NCT00195455 | Feb 2005 → Mar 2007 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 4 | NCT00227942 | Aug 2003 → Nov 2007 | depressive disorder, sleep disorder, initiating and maintaining sleep | Hadine Joffe, MD | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00668603 | Aug 2005 → Mar 2008 | cardiovascular disorder | University of Helsinki | Completed | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 2 | NCT00114517 Comparator | Jul 2004 → Feb 2013 | atherosclerosis | University of Southern California | Completed | No outcome recorded |
| Phase 4 | NCT00837616 Comparator | Jan 2009 → Jun 2012 | Turner syndrome | Nemours Children's Clinic | Completed | No outcome recorded |
| Phase 4 | NCT00472004 Comparator | Feb 2006 → Dec 2009 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| — | NCT00465894 Comparator | Apr 2007 → Jul 2010 | overactive bladder | University of Alabama at Birmingham | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 13 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 17-B Estradiol | “A Prospective, Randomized, Open Label Study To Compare The Efficacy, Safety And Tolerability Of 17-B Estradiol/Trimegestone CC 1 Mg (Totelle) And Tibolone (Livial) In...” NCT00472004 ↗10“17-B estradiol cream 0.5 grams nightly for 6 weeks then two times weekly for 46 weeks.” NCT00465894 ↗ “17-b-Estradiol Patch, .05 mg/day; applied for 7 days” NCT00227942 ↗ |
| Known as | 17-beta-E2 | “This sub-analysis included only ELITE participants with an intact uterus, who were randomized to either daily oral micronized 17-beta-E2 1 mg/day with 4% vaginal micronized P4...” PMID 34736575 ↗ Sep 2021 |
| Known as | 17beta-estradiol | “INTERVENTION: Unopposed micronized 17beta-estradiol (1 mg/d) or placebo.” PMID 11730394 ↗ Dec 2001 |
| Known as | 17β-estradiol | “A total of 643 healthy postmenopausal women were stratified according to time since menopause (<6 years [early postmenopause] or ≥10 years [late postmenopause]) and were...” PMID 27028912 ↗ Mar 2016 |
| Known as | Estrace | “A total of 222 healthy postmenopausal women 46 to 80 years old without CVD symptoms will be randomized to receive either micronized 17B-estradiol (Estrace) 1mg/day, or a...” NCT00115024 ↗ |
| Route | Oral | “Oral 17B-estradiol 1 mg daily” NCT00114517 ↗ |